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Abstract:  Obesity is a global health problem that is gradually affecting each continent of the world. Obesity is a 
heterogeneous disorder, and the biological causes of obesity are complex. The rapid increase in obesity prevalence during 
the past few decades is due to major societal changes (sedentary lifestyle, over-nutrition) but who becomes obese at the 
individual level is determined to a great extent by genetic susceptibility. In this review, we evidence that obesity is a 
strongly heritable disorder, and provide an update on the molecular basis of obesity. To date, nine loci have been involved 
in Mendelian forms of obesity and 58 loci contribute to polygenic obesity, and rare and common structural variants have 
been reliably associated with obesity. Most of the obesity genes remain to be discovered, but promising technologies, 
methodologies and the use of “deep phenotyping” lead to optimism to chip away at the ‘missing heritability’ of obesity in 
the near future. In the longer term, the genetic dissection of obesity will help to characterize disease mechanisms, provide 
new targets for drug design, and lead to an early diagnosis, treatment, and prevention of obesity. 
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INTRODUCTION 
  Since 1980, the mean body mass index (BMI) worldwide 
increased by 0.4-0.5 kg/m per decade in adults 20 years and 
older with 502 million adults worldwide classified as obese 
(BMI  30 kg/m) by 2008 [1]. The worldwide prevalence of 
childhood overweight and obesity have increased from 4.2% 
in 1990 to 6.7% in 2010 and this trend is expected to reach 
9.1% in 2020 [2]. This global health problem is gradually 
affecting each continent of the world.  
  High rates of weight gain during infancy may increase a 
person’s later risk of obesity. There are growing numbers of 
obese children developing diseases formerly considered to 
be an “adult” condition, such as type 2 diabetes, 
nonalcoholic fatty liver disease, sleep apnea and 
hypertension [3]. Obesity-associated diseases are now 
believed to lead to a shortened lifespan [4]. As the incidence 
of obesity-related diseases increase among adults as well as 
children, the consequences of the obesity epidemic on the 
economy of developed countries should be considered as a 
major priority [5].  
  The environmental causes of childhood obesity involve 
an unhealthy diet and physical activity patterns as well as 
early-life factors such as diabetes exposure in utero, larger 
size for gestational age, shorter breastfeeding duration and 
more rapid infant weight gain [6]. However, obesity is the 
result not only of several environmental risk factors, but also 
genetic predisposition [7]. Understanding the many causal   
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factors leading to the complex trait of obesity may help 
develop more targeted and effective therapies. 
PROGRESS IN DEFINING THE MOLECULAR BASIS 
OF OBESITY 
Obesity is a Heritable Disorder 
  Family history of obesity is a well-established risk 
predictor for obesity in childhood. The risk in a child is 2.5-
4-fold higher if one of their parents is obese and 10-fold 
higher if both parents are obese, compared to having both 
parents of normal weight [8]. The familial risk for obesity 
(the risk ratio to be obese for an individual if a first degree 
relative is obese compared with individuals in the population 
who have only normal-weight first degree relatives) is 
comprised between 1.5 and 5 depending on the severity of 
obesity [9]. The familial aggregation of individual’s body 
size is not of a recent concept: Sir Francis Galton mentioned 
this observation in his book “Natural Inheritance” in 1889 
[10]. However, as familial resemblance can be explained by 
shared environments as well as genetic factors, the specific 
influence of genes in determining early-onset obesity was 
investigated 35 years ago with the emergence of twin and 
family studies. 
  In 1977, Feinleib and colleagues [11] studied the 
correlations for weight in 250 monozygotic (100% of 
genome shared) and 264 dizygotic (50% of genome shared) 
male veteran twin pairs and established for the first time that 
familial aggregation for obesity results mainly from genetic 
influence. These results were confirmed in more than 4,000 
monozygotic and dizygotic twin pairs in 1986. Strong 
heritability values for body mass index (BMI) were observed 
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(h=0.84). Heritability represents the proportion of 
phenotypic variation in a population that is attributable to 
genetic variation among individuals [7]. Adoption studies 
have strengthened the evidence of a strong genetic influence 
on human body weight. Body corpulence of adopted children 
was shown to strongly correlate with BMI of their biologic 
parents, whereas no correlation was observed with the BMI 
of their adoptive parents [12]. Furthermore, correlation 
values for BMI of 0.66-0.7 were estimated by Stunkard et al. 
[13] for monozygotic twins reared apart, 0.66-0.74 for 
monozygotic twins reared together, 0.15-0.25 for dizygotic 
twins reared apart and 0.27-0.33 for dizygotic twins reared 
together suggesting that genetic influences on body-mass 
index are substantial, whereas the family environment alone 
has minor influence. Many twin and family studies including 
children or adolescents have been published since these 
pioneering observations, providing heritability values for 
BMI between 0.20 and 0.86 [14-17].  
  Longitudinal studies have demonstrated that heritability 
estimates tend to increase from infancy to childhood [18], 
from childhood to pre-adolescence [15] and from pre-
adolescence to adolescence [17], mirroring the growing 
exposure to obesity-prone environments that subjects with 
genetic propensities tend to favor. Heritability studies have 
also shown that longitudinal BMI change from adolescence 
to young adulthood is an heritable trait and that genetic 
factors modulating BMI levels are only partially shared with 
those modulating change in BMI across time, supporting a 
complex etiology of BMI and BMI change [19]. Heritability 
of obesity as a binary trait, as well as for BMI in all ranges 
of the population, involved overall equates to the same set of 
genes [15].  
  Heritability values for BMI / obesity can be modified by 
specific environmental exposures. A high level of physical 
activity can substantially reduce the influence of genetic 
factors on BMI in both young adults and older adults [20, 
21]. Even if heritability estimations of BMI are similar in 
sex-specific analyses, some sets of genes explaining the BMI 
variation may be different in adolescent as well in adult 
males and females [14, 22]. Ethnicity may also interact with 
the genetic predisposition to obesity and ethnic-specific 
genetic factors are likely to modulate human body weight. 
The proportion of European genome in admixed African or 
Indian Native populations is inversely correlated with BMI, 
supporting the idea that specific gene subsets may account 
for genetic susceptibility to obesity in different ethnic 
backgrounds [23, 24]. Surprisingly, the major societal 
changes that accompanied the transition to an “obesogenic” 
environment (environments that promote gaining weight) did 
not have a major impact on the genetic predisposition to 
obesity. The values of heritability for BMI in childhood 
remain high (h=0.77) even in the current “obesogenic” 
environment [16], and many of the same genes seem to be 
involved in establishing genetic susceptibility to obesity in 
the pre- as in the post-obesity epidemic period [25]. 
Heritability estimates for obesity-related traits are consistent 
among Nigerian, Jamaican and US black people despite 
contrasted environmental conditions and different obesity 
prevalence (5% in Nigeria, 23% in Jamaica and 39% in the 
USA) [26].  
  Beyond BMI, heritability studies have also been 
conducted on endophenotypes related to obesity in young 
individuals. Strong genetic influences have been evidenced 
for intermediate traits such as percentage of body fat [27], 
waist circumference [28], eating behaviour [29], level of 
physical activity [30] or energy expenditure [31]. 
Mendelian Forms of Non-Syndromic Obesity  
  Monogenic forms of obesity refer to a single gene 
disorder leading to a highly penetrant form of the disease. 
The study of extreme human obesity caused by a single gene 
defects has provided a glimpse into the long-term regulation 
of body weight. For example, defects in eight genes involved 
in the neuronal differentiation of the paraventricular nucleus 
and in the leptin/melanocortin pathway lead to monogenic 
forms of early-onset severe obesity, demonstrating the 
critical role of the leptin-melanocortin system critical for 
energy balance in humans [32]. The eight genes are leptin 
(LEP), leptin receptor (LEPR), proopiomelanocortin 
(POMC), prohormone convertase 1 (PCSK1), melanocortin 4 
receptor (MC4R), single-minded homolog 1 (SIM1), brain-
derived neurotrophic factor (BDNF) and its receptor TrkB 
coded by the neurotrophic tyrosine kinase receptor type 2 
gene (NTRK2). 
Recessive Forms of Monogenic Obesity 
  Recessive forms of obesity caused by homozygous / 
heterozygous compound loss of function mutations in five 
genes (LEP, LEPR, POMC, PCSK1 and MC4R) have been 
reported to date [33-37]. Complete inactivation of these five 
genes invariably results in severe hyperphagia and fully 
penetrant form of early-onset extreme obesity in humans. 
Additional phenotypic features associated with these 
recessive forms of obesity are more specific: individuals 
with congenital leptin receptor or leptin deficiency present 
alterations in immune function and frequent childhood 
infections of the respiratory tract associated with high rates 
of premature death. They also manifest delayed puberty due 
to hypogonadotropic hypogonadism, and hypothyroidism 
[33, 34]. The clinical features of individuals with congenital 
leptin receptor deficiency are usually less severe than those 
with congenital homozygous leptin deficiency, and 
hypothyroidism is less common [38]. Individuals with 
complete POMC deficiency present in their early life with 
hypoadrenalism secondary to ACTH deficiency and develop 
hypoglycemia, jaundice and neonatal death which is 
associated with severe liver cholestasis. POMC-deficient 
individuals of European ancestry have pale skin and red hair 
[35], but those with congenital POMC deficiency can harbor 
normal hair and skin pigmentation in other ethnic 
backgrounds [39]. Individuals with complete PCSK1 
deficiency harbor reactive hypoglycemia and perturbations 
in endocrine function including episodes of severe diarrhea 
which indicate an important role for the PC1/3 enzyme in 
enteroendocrine cells [36, 40]. Individuals with complete 
MC4R deficiency harbor an increased lean mass, increased 
bone mineral density and tall stature [37].  
  The study of recessive forms of monogenic extreme 
obesity has been useful in delineating the role of genes from 
the leptin / melanocortin pathway in human physiology but 
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Indeed these recessive forms of obesity are excessively rare 
and are mostly identified in families with a high level of 
consanguinity (consanguinity increases the probability to 
carry two deleterious copies of the same gene). Thus far, 14 
individuals with complete LEP deficiency have been 
identified worldwide, 13 subjects with complete LEPR 
deficiency, seven with complete POMC deficiency, three 
with complete PCSK1 deficiency and 20 with complete 
MC4R deficiency. 
Partial Gene Deficiency and Obesity Features 
  Heterozygosity for deleterious coding mutations in 
MC4R [41] or POMC [42] has been associated with a non 
fully penetrant form of obesity, whereas partial LEP or 
LEPR deficiency has been associated with a higher 
percentage of body fat mass [38, 43]. On the opposite side, 
the eight heterozygous carriers of PCSK1 loss of function 
mutations reported to date, have been described as clinically 
unaffected [44]. This result is intriguing, since heterozygous 
PC1
N222D/+  mice present with an obesity-intermediary 
phenotype [45] and heterozygotes PC1-null mice tend to be 
mildly obese [46]. Even if heterozygous carriers of 
deleterious mutations in MC4R,  POMC,  LEP and LEPR 
present a milder and incompletely penetrant form of obesity 
in comparison with the obligatory severe obesity phenotype 
caused by homozygous / heterozygous compound loss of 
function mutations in the same genes, they are likely to 
contribute for a non-negligible fraction of obesity at the 
population level.  
  MC4R deficiency is the common cause of monogenic 
obesity. Starting from a MC4R loss of function mutation 
frequency of 0.07% reported in the general populations [47], 
we can expect 426,701 heterozygous carriers and only 149 
homozygous / compound heterozygous carriers in the US 
population (N=305,000,000). Using an average penetrance 
of 60% for heterozygous carriers and 100% for homozygous 
and compound heterozygous carriers, as previously reported 
in literature [41], partial MC4R deficiency may explain 
obesity in 256,021 individuals, whereas complete MC4R 
deficiency may be the cause of obesity for only 149 subjects 
in the US population. 
  Haplo-insufficiency for BDNF, TrkB and SIM1 has been 
associated with severe hyperphagic obesity, accompanied by 
syndromic features in humans [48-51]. BDNF and its 
receptor TrkB are involved in proliferation, survival, and 
differentiation of neurons during development and post-natal 
synaptic plasticity in the central nervous system, especially 
in hypothalamic neurons. SIM1, the mammalian homologue 
of Drosophila sim, is a transcription factor playing a major 
role in neuronal differentiation of the paraventricular nucleus 
of the hypothalamus, a critical brain region for food intake 
regulation. No human case of complete deficiency for 
BDNF, TrkB and SIM1 are reported in literature. This is 
consistent with the phenotypes observed in mice. Partial 
deficiency of Bdnf, TrkB or Sim1 in mice induces 
hyperphagia, obesity and developmental features [52-54], 
whereas complete deficiency for Bdnf or Sim1 is lethal [52, 
53] and complete deficiency for TrkB dramatically reduces 
life span [55]. 
Genome Structural Variations 
  In the last few years, the advent of genome-scanning 
technologies has led to the discovery that genetic differences 
among people can derive from lost or duplicated segments of 
chromosomes, called copy number variants (CNVs) or 
structural variants [56]. CNVs contribute significantly to the 
genetic architecture of human obesity. Rare deletions in the 
region p11.2 of the chromosome 16 have been reported in 
about 0.5-0.7% of individuals with severe obesity in two 
independent studies [57, 58], and the link between deletions 
at 16p11.2 and obesity has been confirmed in three follow-
up reports [59-61]. The 16p11.2 deletion interval identified 
in these studies encompasses about 30 genes. The SH2B 
adapter protein 1 (SH2B1) is one of these genes and is an 
excellent candidate gene to link the 16p11.2 deletion to 
obesity. Indeed, SH2B1 modulates leptin sensitivity and 
Sh2b1 knock-out mice develop hyperphagia and obesity 
[62]. In addition, the SH2B1 locus was recently associated 
with common obesity by genome-wide association studies 
(GWAS) [63, 64].  
  A recent study identified 17 rare CNV loci previously 
unreported in the public domain and only found in obese but 
not in lean children of European ancestry. Eight out of 17 
CNVs were also found in obese children of African ancestry, 
but not in lean control subjects of the same ethnicity [65]. 
Finally, Wang et al. [60] investigated the potential role of 
large and rare CNVs in moderate and extreme obesity and 
demonstrated that rare CNVs > 2 Mb were present in 1.3% 
of obese subjects but were absent in lean controls. Several 
CNVs disrupt known candidate genes for obesity, such as 
NAP1L5,  UCP1 and IL15  [60]. The examination of rare 
CNVs offers novel insights into the genetic architecture of 
obesity.  
Polygenic Forms of Obesity  
  The search for gene variants associated with polygenic 
forms of obesity is based on the common disease-common 
variant hypothesis. This hypothesis states that multiple 
common, interacting disease alleles contribute to common 
diseases (each variant at each gene having a modest effect on 
the disease phenotype) and are well represented in human 
populations [66]. Three main approaches have been used to 
identify novel gene variants associated with polygenic 
obesity: candidate gene, genome-wide linkage and genome-
wide association studies. 
Candidate Gene Studies 
  Association studies with candidate genes have been 
widely used for the study of complex traits but have proven 
largely unsuccessful. Several hundreds of obesity candidate 
genes have been selected for genetic association study on the 
biological, physiological or pharmacological evidence of 
their role in body weight regulation, but most of the positive 
association signals initially reported have never been 
consistently replicated in follow-up replication studies [67]. 
Large meta-analyses have been reported for only a small 
number of variants, and so far only two genes have been 
reliably associated with obesity phenotypes using this 
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  Targeted disruption of Mc4r results in obesity in mice, 
loss-of-function coding mutations in MC4R lead to the more 
common form of monogenic human obesity [41, 68] and 
significant evidence of linkage for obesity-related traits has 
been reported on chromosome 18, where the MC4R gene 
resides [69]. MC4R is therefore a highly relevant candidate 
gene for common obesity. Two gain-of-function [70] 
infrequent coding polymorphisms (I251L and V103I) in 
MC4R have been negatively associated with obesity [71, 72]. 
The 103I variant was associated with a 20% lower risk for 
obesity in a meta-analysis of 39,879 subjects of European 
ancestry [72] and the 103I allele carriers had a 31% lower 
risk for obesity in a meta-analysis of 3,526 individuals from 
six East Asian studies [73]. The 251L allele was associated 
with a 50% lower risk for obesity in a meta-analysis of 
11,435 European subjects [72].  
  Loss-of-function rare mutations in the PCSK1 gene have 
been associated with obesity both in humans and rodents [36, 
45]. In addition, four independent genome-wide linkage 
studies for obesity-related traits delineate a common 5.6-Mb 
interval on chromosome 5q where PCSK1 resides [74]. We 
recently showed that the relatively infrequent (minor allele 
frequency: 5%) single nucleotide polymorphism (SNP) 
N221D induces a 10.4% significant reduction of PC1/3 
catalytic activity, and is associated with a 34% increased risk 
for obesity in European populations [74]. The N221D variant 
was also associated with BMI level in an independent 
sample of 32,000 European subjects [64]. These two 
examples indicate that the candidate gene approach can be 
successful if: 1) stringent criteria are applied to gene and 
SNP selection process and 2) large scale association studies 
are performed.  
Genome-Wide Linkage Studies 
  Genome-wide linkage scans involve the genotyping of 
families recruited for the high recurrence of a disease using 
highly polymorphic microsatellite markers that are regularly 
spaced across the whole genome, followed by a calculation 
of the degree of linkage of the marker to a disease trait. 
Genome-wide linkage approaches led to the successful 
identification of > 1,200 genes involved in Mendelian human 
diseases, however the application of genome-wide linkage in 
the analysis of complex genetic traits has been more 
controversial [75]. More than 80 linkage studies for obesity-
related traits have been reported, showing significant 
evidence for linkage (LOD-score > 4) for some of them [76, 
77]. However, a meta-analysis of 37 published studies 
containing data on over 31,000 individuals was unable to 
confirm a major locus for obesity [78], as observed in meta-
analyses for other complex diseases [79].  
  Possible explanations may include genes influencing 
adiposity are of very small effect, with substantial genetic 
heterogeneity and variable dependence on environmental 
factors, but this does not explain why significant peaks of 
linkage have been reported in individual studies at many 
different chromosomal locations. A plausible alternative 
explanation is that rare variants with high disease penetrance 
may be a common explanation for linkage peaks observed in 
complex traits like obesity [42, 80]. This is in line with 
statistical simulations predicting that odds-ratios must be 
high (OR > 2) to induce significant peaks of linkage in 
modest family sample sets [75]. Attempts to identify new 
obesity genes by genome-wide linkage strategies have been 
mostly unsuccessful, genetic variants in only two genes have 
shown association with obesity, contribution to the initial 
linkage peak and have been confirmed in subsequent 
replication studies.  
  The only significant evidence of linkage for childhood 
obesity was obtained on chromosome 6q22.31-q23.2 in 115 
French pedigrees [76]. Restriction of the linkage interval 
under study by comparison of eight independent linkage 
studies and subsequent positional candidate gene approach 
led to the identification of a three-allele risk haplotype 
(K121Q, IVS20delT-11, AG +1044TGA; QdelTG) in the 
ectonucleotide pyrophosphatase / phosphodiesterase 1 
(ENPP1) gene that showed association with childhood 
obesity and contribution to the observed linkage with 
childhood obesity [81]. The ENPP1 QdelTG haplotype was 
associated with adult moderate and morbid obesity and type 
2 diabetes and was also associated with increased serum 
levels of soluble ENPP1 protein in children [81]. 
Interestingly,  ENPP1 gene variation was found to be 
independently associated with obesity-related traits in 
Mexican American pedigrees by a positional candidate gene 
approach [82]. The function of the gene can be directly 
related to obesity and type 2 diabetes as ENPP1 inhibits 
insulin receptor signaling [83]. The link between ENPP1 and 
insulin resistance has been evidenced in genetic mouse 
models as well [84]. Insulin resistance in brain induces 
hyperphagia and obesity in mice [85] and insulin resistance 
is a strong predictor of subsequent development of obesity in 
children [86]. The association of the ENPP1 risk haplotype 
with childhood obesity has been replicated in a German 
study [87] but further replication is needed to provide an 
unequivocal confirmation. 
  In 2002, Stone and colleagues [77] identified a major 
predisposition locus for sever obesity in White American 
females on chromosome 4p15-p14. Subsequent positional 
cloning effort by the same team led to the identification of a 
non-synonymous polymorphism (R125W) in the TBC1D1 
gene associated with severe familial obesity in women only 
and accounting for the majority of the evidence of linkage on 
chromosome 4p15-14 [88]. The association of the TBC1D1 
R125W polymorphism with familial severe obesity in 
females and linkage at 4p15-p14 was replicated in an 
independent French cohort [89]. Further replication is now 
needed at this stage, and the gender-specific association of 
the R125W variant with obesity remains unexplained. 
TBC1D1 protein function involves adipogenesis process 
[90], insulin signalling [91] and lipid use in skeletal muscle 
[92] and inactivation of Tbc1d1 confers leanness in mice 
[92]. These observations further support the candidacy of 
TBC1D1 as a ‘thrifty’ gene as recently proposed by 
Koumanov et al. [93]. 
Genome-Wide Association Studies 
  Genome-wide association studies (GWAS) are a 
relatively new way for scientists to identify genes involved 
in human diseases and have revolutionized the search for 
genetic common variants contributing to complex diseases. 
This method interrogates the genome for several hundred-
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genome, and identifies the SNPs that occur more frequently 
in people with a particular disease than in those without the 
disease. As of June 2010, there have been more than 900 
published genome-wide associations for 165 traits 
(http://www.genome.gov). The combinations of three major 
breakthroughs have made genome-wide comprehensive 
association studies possible: 1) the emergence of the notion 
of linkage disequilibrium block [94], the determination of 
the human genome SNP map through the International 
Hapmap Consortium [95] (this led to the conclusion that 
80% of the common genetic variation (>14 million variants) 
in subjects of European ancestry can be captured by 
genotyping 300,000 carefully selected single nucleotide 
polymorphisms (SNPs) [96]); 2) the development and 
commercialization of new methods for high throughput 
genotyping using SNP microarrays [97] and 3) the 
recruitment of large scale case control and population-based 
cohorts with both DNA and phenotypes available [98].  
  In 2007, four different approaches led to the 
identification of variation in the intron 1 of Fat mass and 
obesity associated (FTO) gene as the major contributor to 
polygenic obesity in populations of European ancestry [99-
102]. Frayling et al. [99] identified FTO through a GWAS 
for type 2 diabetes in UK subjects, variants in the FTO gene 
showing a strong association with T2D mediated through 
BMI [99]. Scuteri et al. [101] identified FTO by using a 
GWAS approach for BMI in the genetically isolated 
population of Sardinia. Hinney et al. [102] identified FTO by 
using GWAS for early-onset extreme obesity in a German 
case control study. Dina et al. [100] unexpectedly found a 
strong association between FTO and obesity, by performing 
a population structure approach with a set of 48 SNPs in a 
French obesity case control design. The 16% of adults of 
European ancestry who were homozygous for the risk allele 
weighed about 3 kilograms more and had 1.67-fold increased 
odds of obesity when compared with those not inheriting a 
risk allele [99]. Apart from European populations, FTO was 
shown to be the top association signal for BMI (P=1 x 10
-7) 
in a recent GWAS including 8,842 Korean subjects [103].  
  Four large GWAS meta-analyses in general populations 
of European descent (16,876 < N < 123,865) confirmed the 
strong association of the FTO locus with BMI and identified 
35 additional SNPs in 33 loci robustly (P < 5 x 10
-7) 
associated with BMI (Table 1). Multiple independent 
association signals were reported at the FTO,  MC4R and 
BDNF loci [63, 104]. Altogether these loci only explained 
1.45% of the variance in BMI (0.34% explained by the SNP 
in intron 1 of FTO alone), suggesting that many additional 
common genetic variants associated with BMI remain to be 
discovered [104]. Each additional risk allele increases BMI 
of 0.17 kg/m and body weight of 435-551 grams in adults of 
160-180 cm in height [104]. Interestingly, SNPs that 
modulate BMI in general adult populations are also 
associated with BMI in pediatric populations [105], and are 
associated with an increased risk for early-onset [64, 104] or 
adult obesity [106].  
  The genetic architecture of extreme childhood and adult 
obesity has also been investigated using case control GWAS 
designs [102, 107-109]. Nine loci have been associated with 
extreme obesity at the genome-wide level, five of them 
influencing BMI / waist circumference as well as risk for 
extreme obesity (FTO, MC4R, TMEM18, MSRA, NPC1) 
[102, 104, 107-110], four loci being more specific of genetic 
risk for extreme obesity (MAF, PTER, PRL, SDCCAG8) 
[107, 109] (Table 1). Overall, these data indicate that the 
genetic architecture of BMI and extreme obesity are mostly 
overlapping in children as well as adults, and that extreme 
obesity may represent the extreme of the phenotypic 
spectrum of BMI rather than a distinct condition [108]. 
Several of the likely causal obesity genes identified through 
GWAS studies (FTO, MC4R, POMC, SH2B1, BDNF, NPC1, 
NRXN3 and NEGR1) are highly expressed or known to act in 
the central nervous system, indicating a key role for central 
regulation of food intake in obesity susceptibility in line with 
monogenic forms of human obesity [64, 104].  
  Beyond the study of BMI, four GWAS have investigated 
the genetic architecture of body fat distribution, estimated by 
waist circumference (WC) or waist to hip ratio (WHR) 
measurements [110-113]. Nineteen loci have been identified 
and five of them only are associated with BMI / obesity 
(FTO, MC4R,  NRXN3, TFAP2B, MSRA) (Table 1). 
However, it is to noted that WC or WHR measurements 
were adjusted for BMI in the two larger GWAS meta-
analyses, to identify SNPs associated with central adiposity 
and those independently of overall adiposity [110, 113]. The 
biological role of several likely causal candidate genes 
identified by GWAS pinpoint a key role of adipose tissue 
development and function in determining body fat 
distribution [113].  
  Common copy number variants (CNVs) are in high 
linkage disequilibrium with SNPs in the human genome 
suggesting that disease-associated common structural 
variants can be identified by SNP-based whole-genome 
association studies [114]. Using a SNP tagging approach, a 
45-kb deletion near the NEGR1 gene and a 21-kb deletion 50 
kb upstream of GPRC5BT have been recently and 
convincingly associated with BMI variation [64, 104], and a 
2.8-kb common duplication 87 kb from the LY86 gene has 
been conclusively associated with WHR [113]. A common 
CNV on chromosomes 10p11.22 has been associated with 
BMI in a Chinese population [115] and covers four genes, 
one of them (PPYR1) being a plausible obesity candidate 
gene [115]. The association of CNV 10p11.22 with obesity 
has been confirmed in two independent studies [60, 61]. 
CNVs are plausible functional causal variants due to their 
potential impact on gene expression [116], and genes located 
nearby these CNVs might be prioritized for fine mapping 
and functional follow-up. 
FUTURE PROSPECTS 
New Approaches to Chip Away at the “Missing 
Heritability” of Obesity 
  Although there is strong evidence that heritability of 
human body weight is high, only a small fraction of the 
variance in BMI can be explained by the current list of 
genetic factors suggesting potential sources of missing 
heritability [104]. One hypothesis about missing heritability 
from GWAS has focused on the possible contribution of 
variants of low minor allele frequency (MAF), defined as 
0.5<MAF<5 %, or of rare variants (MAF<0.5 %). GWA Genetics of Obesity  Current Genomics, 2011, Vol. 12, No. 3    159 
Table  1.  Sixty-One Common Gene Variants at 58 Loci are Associated with Obesity Phenotypes at a Genome-Wide Level of 
Significance (P < 5 x 10
8) 
Nearest Gene  Polymorphism  Phenotype  Reference 
FTO  rs1421085 / rs9939609  body mass index, extreme obesity  [99, 100] 
MC4R  rs17782313  body mass index, extreme and childhood obesity  [107, 109, 130] 
PCSK1  rs6232 extreme  obesity  [74] 
PCSK1  rs6234 / rs6235  extreme obesity  [74] 
CTNNBL1  rs6013029  body mass index  [139] 
TMEM18  rs6548238  body mass index, childhood obesity  [64, 109] 
GNPDA2  rs10938397  body mass index  [64] 
SH2B1  rs7498665  body mass index  [64] 
KCTD15  rs11084753  body mass index  [64] 
MTCH2  rs10838738  body mass index  [64] 
NEGR1  rs2815752  body mass index  [64] 
NPC1  rs1805081 extreme  obesity  [107] 
MAF  rs1424233 extreme  obesity  [107] 
PTER  rs10598503 extreme  obesity  [107] 
PRL  rs4712652 extreme  obesity  [107] 
SEC16B  rs10913469  body mass index  [63] 
ETV5  rs7647305  body mass index  [63] 
AIF1  rs2844479  body mass index  [63] 
BDNF  rs6265  body mass index  [63] 
BDNF  rs925946  body mass index  [63] 
FAIM2  rs7138803  body mass index  [63] 
FTO  rs6499640  body mass index  [63] 
SDCCAG8  rs12145833 childhood  obesity  [109] 
TNKS  rs17150703 childhood  obesity  [109] 
TFAP2B  rs987237  waist circumference, body mass index  [104, 110] 
MSRA  rs7826222 waist  circumference  [110] 
LYPLAL1  rs4846567  waist to hip ratio  [110, 113] 
NRXN3  rs10146997  waist circumference, body mass index  [104, 112] 
C12orf51  rs2074356  waist to hip ratio  [103] 
GPRC5BB  rs12444979  body mass index  [104] 
POMC  rs713586  body mass index  [104] 
MAP2K5  rs2241423  body mass index  [104] 
GIPR  rs2287019  body mass index  [104] 
FANCL  rs887912  body mass index  [104] 
TNNI3K  rs1514175  body mass index  [104] 
LRRN6C  rs10968576  body mass index  [104] 
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(Table 1). Contd….. 
Nearest Gene  Polymorphism  Phenotype  Reference 
FLJ35779  rs2112347  body mass index  [104] 
SLC39A8  rs13107325  body mass index  [104] 
TMEM160  rs3810291  body mass index  [104] 
CADM2  rs13078807  body mass index  [104] 
LRP1B  rs2890652  body mass index  [104] 
PRKD1  rs11847697  body mass index  [104] 
MTIF3  rs4771122  body mass index  [104] 
ZNF608  rs48361333  body mass index  [104] 
PTBP2  rs1555543  body mass index  [104] 
TUB  rs4929949  body mass index  [104] 
HMGA1  rs206936  body mass index  [104] 
MC4R  rs7227255  body mass index  [104] 
RSPO3  rs9491696  waist to hip ratio  [113] 
VEGFA  rs6905288  waist to hip ratio  [113] 
TBX15/WARS2  rs984222  waist to hip ratio  [113] 
NFE2L3  rs1055144  waist to hip ratio  [113] 
GRB14  rs10195252  waist to hip ratio  [113] 
DNM3/PIGC  rs1011731  waist to hip ratio  [113] 
ITPR2/SSPN  rs718314  waist to hip ratio  [113] 
LY86  rs1294421  waist to hip ratio  [113] 
HOXC13  rs1443512  waist to hip ratio  [113] 
ADAMTS9  rs6795735  waist to hip ratio  [113] 
ZNRF3/KREMEN1  rs4823006  waist to hip ratio  [113] 
NISCH/STAB1  rs6784615  waist to hip ratio  [113] 
CPEB4  rs6861681  waist to hip ratio  [113] 
 
genotyping arrays used in the first waves of GWAS 
classically included 300,000-500,000 SNPs and they 
provided only an exhaustive coverage of the common SNP 
variation (MAF > 5%) in the genome [96], signifying that 
rare variants associated with complex diseases have not been 
captured in these studies. Low frequency variants may have 
much stronger effects on the disease risk than common 
variants without demonstrating clear Mendelian segregation, 
and may explain an important part of the missing heritability 
[117]. Common and rare structural variation, including 
CNVs, such as insertions and deletions and copy neutral 
variation, may account for some of the unexplained 
heritability [118]. Imprinted genes [119], gene x gene and 
gene x environment interactions [120, 121], ethnic-specific 
disease loci [103] or disease-associated haplotypes that are 
not identified by single SNP analyses [122] may also 
account for a substantial part of the missing heritability of 
obesity.  
  The establishment of many population-based studies that 
have collected genome-wide data on genetic variation has 
recently led to the formation of consortia facilitating 
powerful GWAS meta-analyses for BMI or WHR [104, 
113]. Upcoming GWAS meta-analyses for continuous or 
extreme obesity phenotypes in larger sample sizes are likely 
to complete the current list of obesity predisposing genes, 
and will enable gene x environment or gene x gene well-
powered GWAS studies. The completion of family-based 
GWAS for obesity-related traits will be useful to identify 
disease-associated imprinted loci and haplotypes [118]. The 
integration of data issued from expression and DNA arrays 
offers the possibility to identify true disease-associated SNPs 
that do not reach a genome-wide significant level of 
association in initial GWAS analysis. This approach recently 
led to the identification of F13A1 as a valuable candidate 
gene for obesity [123], and SNP prioritization programs 
integrating expression QTL information are now emerging Genetics of Obesity  Current Genomics, 2011, Vol. 12, No. 3    161 
[124]. A new generation of dense DNA arrays (including up 
to 5 millions SNP and CNVs) based on the detailed 
information of rare and common single nucleotide and copy 
number variation in the human genome provided by the 1000 
Genome project [125], combined with the development of 
adequate statistical methodologies [126], will enable the 
identification of novel rare variants predisposing to obesity. 
Numerous rare variants may be detected in a gene or region 
but they may have disparate effects on phenotype. One 
strategy to study associations between such variants and 
disease might be pooling rare variants together using logical 
criteria and analyzing them as a single group [127].  
  Others strategies may shortly lead to a more exhaustive 
picture of the rare variants explaining highly penetrant forms 
of obesity. High-resolution homozygosity mapping in large 
consanguineous pedigrees is a powerful approach to discover 
novel obesity loci with a recessive mode of inheritance, as 
recently exemplified in syndromic forms of obesity [128]. 
Exome capture and parallel sequencing strategies in carefully 
selected unrelated cases and controls have proven successful 
for gene identification [129] and this approach should be 
successfully extended in the future to large pedigrees with a 
Mendelian pattern of obesity. The high occurrence of 
Mendelian patterns of inheritance observed in 
multigenerational pedigrees with extreme obesity, the fact 
that > 130 genes lead to a severe obesity phenotype in mice 
when down or up-regulated, and that every single monogenic 
gene explains a weak fraction of human obesity suggests that 
many monogenic genes remain to be discovered [77]. In 
addition to the deletion at 16p11.2, the identification of 
additional rare structural variants associated with highly 
penetrant forms of obesity by genome-wide association 
approaches are likely to be followed by systematic 
resequencing approaches for genes located in genome 
structural variation intervals, that may help to identify 
additional Mendelian obesity genes. Altogether, these novel 
methodologies are likely to fill the gap of the “missing 
heritability” of obesity in the near future. 
New Phenotypes for New Genes 
On the Use of BMI Variable in GWAS 
  Heritability studies in young and older adults have 
recently shown that genetic factors modulating BMI levels 
are only partially shared with those modulating change in 
BMI across time, supporting a complex etiology of BMI 
level and BMI change [19]. As recent GWAS have focused 
on the BMI level only [63, 64, 104, 130], an interesting 
perspective would be to perform a GWAS for parameters 
related to BMI change across life span in order to find novel 
SNPs robustly associated with more complex obesity 
phenotypes. The ‘set point’ theory proposes the existence of 
a feedback biological control system that regulates total body 
weight to a constant ‘body-inherent’ weight [131]. However, 
observational studies suggest that a set point in humans, if 
any, is loose rather than tightly controlled [132] and BMI 
variance in adulthood is expected to vary significantly in 
populations, from ‘BMI stable’ to ‘BMI yo-yo’ longitudinal 
patterns. In line with a growing interest for the genetic 
analysis on the variance of quantitative traits [133], it may be 
interesting to estimate the heritability of BMI variance across 
time and, if substantial, to identify gene variants associated 
with BMI variance by GWAS.  
  Recent GWAS meta-analyses for BMI [63, 64, 104, 130] 
have collected BMI information in individuals living in a 
wide range of heterogeneous environments. This approach 
has been successful but gene variants associated with BMI in 
specific environmental exposures may have been missed. 
Knowing that the inter-individual response for BMI 
distribution to a similar environment can differ considerably 
and genetic factors must explain these differences in 
populations [16], GWAS for BMI in specific environmental 
conditions may lead to the discovery of novel predisposing 
loci. It may be of particular interest to perform GWAS for 
BMI dynamic change in response to a brutal obesity-prone 
environment modification. From this point of view, the 
genetic analysis of BMI response to antipsychotic drugs 
intake, pregnancy or smoking cessation would be relevant, as 
1) large inter-individual variability, likely to be modulated 
by genetic factors, is observed for BMI variation in response 
to these specific environmental exposures and 2) these 
conditions predispose to subsequent obesity development. 
GWAS for the BMI response to lifestyle intervention, 
pharmacotherapy and bariatric surgery may also be useful to 
identify the genes involved in efficient responses to specific 
treatments.  
On the Use of ‘Deep Phenotyping’ in GWAS 
  Beyond the study of BMI, GWAS for additional 
phenotypes such as waist circumference or waist to hip ratio 
led to the identification of 14 novel genetic loci [110-113]. 
These data strongly argue for the use of different measures 
of adiposity in GWAS. Although widely used as “the obesity 
phenotype” in gene-search studies, BMI is not a good proxy 
of body fat content, especially at the individual level [134]. 
Whereas BMI is significantly associated with fat mass in 
obese subjects, there is little or no association between BMI 
and fat mass in normal weight and underweight subjects. At 
a given BMI, fat mass may vary by more than 100% [132]. 
Because phenotypic precision is major for genetic 
interrogation, the use of "deep phenotyping" information 
may help to dissect the genetic influences of obesity [135]. 
GWAS for endophenotypes such as body fat content and 
percentage of fat mass estimated by dual-emission X-ray 
absorptiometry, behavioral food intake measured by ad 
libitum meal test [136] and energy expenditure estimated by 
room respiration calorimetry [136] may provide highly 
relevant information.  
 Müller  et al. [137] considered that the genetic basis of 
body weight regulation is unlikely to be fully discernable in 
individuals who are at stable energy equilibrium (i.e., at a 
stable body weight). They proposed to use dynamic 
phenotypes, including energy intake, energy expenditure and 
partitioning under conditions of controlled over and 
underfeeding rather than static phenotypes such as body 
composition and energy homeostasis. Such dynamic 
phenotypes should provide a more sensible basis for future 
genetic studies on obesity [132]. 
  In conclusion, nine loci have been identified in 
Mendelian forms of non-syndromic obesity, and 58 loci have 
been robustly associated with polygenic obesity up to now 162    Current Genomics, 2011, Vol. 12, No. 3  Choquet and Meyre 
but these loci explain a small fraction of the heritability for 
obesity. It seems that we are only at ‘the end of the 
beginning’ of the search for genetic variants that predispose 
to obesity. Innovative methodologies and technologies 
presented in detail here lead to optimism, and there is no 
doubt that we will live a prolific period of discovery in 
human obesity genetics in the upcoming years. The time 
required to shift from scientific discoveries to clinical 
applications is often underestimated [138] but on the longer 
term, the exhaustive genetic dissection of obesity will help to 
characterize the disease mechanisms, to provide new targets 
for drug design, and to lead to an efficient diagnosis, 
treatment, and prevention of obesity. 
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